U.S. Approval Of Edwards Sapien Transcatheter Heart Valve Possible In 2009

Edwards Lifesciences is on track to begin a U.S. pivotal trial in early 2007 for its Sapien transcatheter aortic heart valve, making FDA approval possible by late 2009, according to the company